ENSEMBLE PLUS: final results of shorter ocrelizumab infusion from a randomized controlled trial.
Hartung HP, Berger T, Bermel RA, Brochet B, Carroll WM, Holmøy T, Karabudak R, Killestein J, Nos C, Patti F, Perrin Ross A, Vanopdenbosch L, Vollmer T, Buffels R, Garas M, Kadner K, Manfrini M, Wang Q, Freedman MS.
Hartung HP, et al. Among authors: garas m.
J Neurol. 2024 Apr 22. doi: 10.1007/s00415-024-12326-z. Online ahead of print.
J Neurol. 2024.
PMID: 38649522